Charles River Laboratories Total Long-Term Assets 2010-2024 | CRL

Charles River Laboratories total long-term assets from 2010 to 2024. Total long-term assets can be defined as the sum of all assets classified as non-current
  • Charles River Laboratories total long-term assets for the quarter ending September 30, 2024 were $6.509B, a 5.62% increase year-over-year.
  • Charles River Laboratories total long-term assets for 2023 were $6.586B, a 6.86% increase from 2022.
  • Charles River Laboratories total long-term assets for 2022 were $6.164B, a 7.19% increase from 2021.
  • Charles River Laboratories total long-term assets for 2021 were $5.75B, a 34.05% increase from 2020.
Charles River Laboratories Annual Total Long-Term Assets
(Millions of US $)
2023 $6,586
2022 $6,164
2021 $5,750
2020 $4,290
2019 $3,671
2018 $2,958
2017 $2,103
2016 $2,055
2015 $1,509
2014 $1,291
2013 $1,080
2012 $1,101
2011 $1,132
2010 $1,180
2009 $1,608
Charles River Laboratories Quarterly Total Long-Term Assets
(Millions of US $)
2024-09-30 $6,509
2024-06-30 $6,449
2024-03-31 $6,485
2023-12-31 $6,586
2023-09-30 $6,163
2023-06-30 $6,268
2023-03-31 $6,251
2022-12-31 $6,164
2022-09-30 $5,967
2022-06-30 $6,136
2022-03-31 $5,742
2021-12-31 $5,750
2021-09-30 $5,679
2021-06-30 $5,452
2021-03-31 $4,386
2020-12-31 $4,290
2020-09-30 $4,073
2020-06-30 $4,006
2020-03-31 $3,994
2019-12-31 $3,671
2019-09-30 $3,610
2019-06-30 $3,615
2019-03-31 $3,060
2018-12-31 $2,958
2018-09-30 $2,958
2018-06-30 $2,976
2018-03-31 $2,158
2017-12-31 $2,103
2017-09-30 $2,084
2017-06-30 $2,036
2017-03-31 $1,997
2016-12-31 $2,055
2016-09-30 $2,036
2016-06-30 $2,061
2016-03-31 $1,466
2015-12-31 $1,509
2015-09-30 $1,454
2015-06-30 $1,256
2015-03-31 $1,233
2014-12-31 $1,291
2014-09-30 $1,236
2014-06-30 $1,271
2014-03-31 $1,061
2013-12-31 $1,080
2013-09-30 $1,096
2013-06-30 $1,102
2013-03-31 $1,111
2012-12-31 $1,101
2012-09-30 $1,110
2012-06-30 $1,095
2012-03-31 $1,118
2011-12-31 $1,132
2011-09-30 $1,129
2011-06-30 $1,157
2011-03-31 $1,184
2010-12-31 $1,180
2010-09-30 $1,553
2010-06-30 $1,549
2010-03-31 $1,573
2009-12-31 $1,608
2009-09-30 $1,625
2009-06-30 $1,584
2009-03-31 $1,506
Sector Industry Market Cap Revenue
Medical Medical Services $9.516B $4.129B
Charles River Laboratories International, Inc. is a full service, early-stage contract research organization. The company provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and leading academic institutions globally accelerate their research and drug development efforts. The company has a diverse portfolio of discovery and safety assessment services, both Good Laboratory Practice (GLP) and non-GLP. This helps support its clients from target identification through non-clinical development. Charles River also provides a line of products and services to support clients' manufacturing activities. Utilizing the company's broad portfolio of products and services, clients can create a more flexible drug development model, aiming cost reduction, productivity enhancement and increase in speed to market. Charles River currently has three reporting segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA) and Manufacturing Support.
Stock Name Country Market Cap PE Ratio
Elevance Health (ELV) United States $91.424B 11.34
Cencora (COR) United States $47.484B 17.51
DiDi Global (DIDIY) China $23.330B 0.00
Natera (NTRA) United States $21.401B 0.00
ICON (ICLR) Ireland $16.136B 14.37
Viatris (VTRS) United States $15.576B 4.80
Avantor (AVTR) United States $13.422B 20.12
Revvity (RVTY) United States $13.376B 23.24
CochLear (CHEOY) Australia $12.844B 0.00
BioMerieux (BMXMF) France $12.666B 0.00
Solventum (SOLV) United States $11.583B 0.00
Medpace Holdings (MEDP) United States $9.789B 27.58
Doximity (DOCS) United States $9.620B 56.63
HealthEquity (HQY) United States $8.966B 48.66
Sonic Healthcare (SKHHY) Australia $8.758B 0.00
Bausch + Lomb (BLCO) Canada $6.885B 32.05
Life Times (LTH) United States $5.085B 33.66
Sotera Health (SHC) United States $3.855B 20.62
Organon (OGN) United States $3.757B 3.79
BrightSpring Health Services (BTSG) United States $3.247B 69.07
Surgery Partners (SGRY) United States $2.892B 32.97
PACS (PACS) United States $2.606B 0.00
Concentras Parent (CON) United States $2.581B 0.00
Ardent Health Partners (ARDT) United States $2.375B 0.00
Premier (PINC) United States $2.143B 11.15
Alignment Healthcare (ALHC) United States $2.126B 0.00
Ryman Healthcare (RYHTY) New Zealand $2.036B 0.00
GeneDx Holdings (WGS) United States $1.952B 0.00
GoodRx Holdings (GDRX) United States $1.616B 42.40
Teladoc Health (TDOC) United States $1.537B 0.00
Pediatrix Medical (MD) United States $1.255B 12.28
CareDx (CDNA) United States $1.183B 0.00
Progyny (PGNY) United States $1.164B 23.57
Establishment Labs Holdings (ESTA) $1.050B 0.00
AMN Healthcare Services Inc (AMN) United States $0.954B 6.46
QDM (QDMI) Hong Kong, SAR China $0.790B 20.69
Embecta (EMBC) United States $0.778B 5.18
SBC Medicals (SBC) United States $0.677B 0.00
Agilon Health (AGL) United States $0.655B 0.00
InnovAge Holding (INNV) United States $0.647B 0.00
Auna S.A (AUNA) Luxembourg $0.536B 0.00
Sonida Senior Living (SNDA) United States $0.425B 0.00
DocGo (DCGO) United States $0.410B 15.46
Enhabit (EHAB) United States $0.366B 31.61
COMPASS Pathways (CMPS) United Kingdom $0.326B 0.00
LifeMD (LFMD) United States $0.241B 0.00
ModivCare (MODV) United States $0.223B 12.09
Sera Prognostics (SERA) United States $0.209B 0.00
Beauty Health (SKIN) United States $0.200B 0.00
Biodesix (BDSX) United States $0.180B 0.00
Nutex Health (NUTX) United States $0.156B 0.00
Ascend Wellness Holdings (AAWH) United States $0.100B 0.00
So-Young (SY) China $0.092B 22.25
MultiPlan (MPLN) United States $0.084B 0.00
Singular Genomics Systems (OMIC) United States $0.054B 0.00
OncoCyte (OCX) United States $0.043B 0.00
NeueHealth (NEUE) United States $0.041B 1.08
Co-Diagnostics (CODX) United States $0.034B 0.00
Pheton Holdings (PTHL) China $0.030B 0.00
IceCure Medical (ICCM) Israel $0.028B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.020B 0.00
Oncology Institute (TOI) United States $0.014B 0.00
SeaStar Medical Holding (ICU) United States $0.009B 0.00
XWELL (XWEL) United States $0.008B 0.00
Intelligent Bio Solutions (INBS) United States $0.006B 0.00
BioNexus Gene Lab (BGLC) $0.005B 0.00
KindlyMD (KDLY) United States $0.005B 0.00
ISpecimen (ISPC) United States $0.004B 0.00
NewGenIvf Group (NIVF) Thailand $0.002B 0.00
Aclarion (ACON) United States $0.002B 0.00
Cano Health (CANOQ) United States $0.001B 0.00